TransCode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update

Go back to TransCode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 1.69 -0.08 (4.52%)
Previous Close $1.77    52 Week High
Open $1.84    52 Week Low
Day High $2.39    P/E N/A 
Day Low $1.62    EPS
Volume 355,494